Deep, focused next-era sequencing has uncovered that subclonal mutations (i.e., These existing in only a portion of tumor cells) may be detected for all driver genes and they are connected with quick ailment development and very poor final result.11–13 This is particularly pertinent for TP53 mutations provided The truth that, as described under,